- Lexaria Bioscience continues to advance the effectiveness of its proprietary DehydraTECH technology, a formulation that teams with drug substances such as nicotine and cannabidiol to quickly carry those drugs into a user’s blood stream
- Recent concerns about the safety of vape products and ongoing concerns about the safety of tobacco are opening doors to Lexaria’s edible technology
- Newly legalized cannabis-infused edibles began hitting store shelves nationwide in Canada last month, presenting Lexaria with new potential licensing outlets for its increasingly effective products
If 2019 was the year when vape users discovered the potential perils of using untested off-brand products, 2020 may well be the year when vape users share the common woe of struggling to beat an addiction.
The U.S. Centers for Disease Control and Prevention (CDC) reported at year’s end that 2,561 people had been hospitalized with the vape-related lung illness now known as ‘e-cigarette or vaping product use-associated lung injury’ (EVALI) as of December 27, that the illness had afflicted every U.S. state and two territories, and…
NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://cnw.fm/LXRP
About CBDWire
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask Our Editor
CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
[email protected]
CBDWire is part of the InvestorBrandNetwork.